Mixed cryoglobulinemia and thyroid autoimmune disorders

Clinica Terapeutica

Volumn 164, Issue SUPPL.4, 2013, Pages

  Fallahi, P ^a   Ferrari, S M ^a   Giuggioli, D ^b   Corrado, A ^a   Fabiani, S ^a   Marchi, S ^a   Ferri, C ^b   Antonelli, Alessandro ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Chemokines; Cryoglobulinemia; Hepatitis C; Hypothyroidism; Thyroid neoplasms; Thyroiditis

Indexed keywords

AUTOANTIBODY; INTERFERON; THYROGLOBULIN ANTIBODY; THYROID ANTIBODY; THYROID PEROXIDASE;

AUTOIMMUNE THYROIDITIS; AUTOIMMUNITY; COHORT ANALYSIS; CRYOGLOBULINEMIA; DISEASE ASSOCIATION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HYPOTHYROIDISM; IMMUNOTHERAPY; INFECTION RISK; IODINE DEFICIENCY; REVIEW; SEX DIFFERENCE; THYROID CANCER; THYROID DISEASE; THYROID FUNCTION; ADULT; AUTOIMMUNE DISEASE; COMPLICATION; IMMUNOLOGY;

ADULT; AUTOIMMUNE DISEASES; CRYOGLOBULINEMIA; HEPATITIS C; HUMANS; THYROID DISEASES;

EID: 84885716694     PISSN: 00099074     EISSN: 19726007     Source Type: Journal    
DOI: 10.7417/CT.2013.1598     Document Type: Review

References (58)

1. Alter MJ. Epidemiology of hepatitis C virus infection. World J Gastroenterol 2007; 13:2436-41
2. Blackard JT, Kemmer N, Sherman KE. Extrahepatic replication of HCV: insights into clinical manifestations and biological consequences. Hepatol 2006; 44:15-22
3. Antonelli A, Ferri C, Fallahi P, et al. Type 2 diabetes in hepatitis C-related mixed cryoglobulinaemia patients. Rheumatology (Oxford) 2004; 43:238-40
4. Antonelli A, Ferri C, Fallahi P, et al. Thyroid disorders in chronic hepatitis C virus infection. Thyroid 2006; 16:563-72
5. Ferri C, Antonelli A, Mascia MT, et al. B-cells and mixed cryoglobulinemia. Autoimmun Rev 2007; 7:114-20
6. Tran A, Quaranta JF, Benzaken S, et al. High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy. Hepatol 1993;18:253-7
7. Fernandez-Soto L, Gonzalez A, Escobar-Jimenez F, et al. Increased risk of autoimmune thyroid disease in hepatitis C vs hepatitis B before, during, and after discontinuing interferon therapy. Arch Intern Med 1998; 158:1445-8
8. Preziati D, La Rosa L, Covini G, et al. Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a. Eur J Endocrinol 1995;132:587-93
9. Antonelli A, Ferri C, Pampana A, et al. Thyroid disorders in chronic hepatitis C. Am J Med 2004;117:10-3
10. Metcalfe RA, Ball G, Kudesia G, et al. Failure to find an association between hepatitis C virus and thyroid autoimmunity. Thyroid 1997; 7:421-4
11. Boadas J, Rodriguez-Espinosa J, Enriquez J, et al. Prevalence of thyroid autoantibodies is not increased in blood donors with hepatitis C virus infection. J Hepatol 1995; 22:611-5
12. Donati L, Antonelli A, Bertoni F, et al. Clinical picture of endemic cretinism in central Apennines (Montefeltro). Thyroid 1992; 2:283-90
13. Indolfi G, Stagi S, Bartolini E, et al. Thyroid function and antithyroid autoantibodies in untreated children with vertically acquired chronic hepatitis C virus infection. Clin Endocrinol (Oxf) 2008;68:117-21
14. Watanabe U, Hashimoto E, Hisamitsu T, et al. The risk factor for development of thyroid disease during interferon-alpha therapy for chronic hepatitis C. Am J Gastroenterol 1994; 89:399-403
15. Carella C, Amato G, Biondi B, et al. Longitudinal study of antibodies against thyroid in patients undergoing interferonalpha therapy for HCV chronic hepatitis. Horm Res 1995; 44:110-4
16. Roti E, Minelli R, Giuberti T, et al. Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-alpha. Am J Med 1996; 101:482-7
17. Marazuela M, Garcia-Buey L, Gonzalez-Fernandez B, et al. Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon-alpha therapy. Clin Endocrinol (Oxf) 1996; 44:635-4218
18. Carella C, Mazziotti G, Morisco F, et al. The addition of ribavirin to interferon-alpha therapy in patients with hepatitis C virus-related chronic hepatitis does not modify the thyroid autoantibody pattern but increases the risk of developing hypothyroidism. Eur J Endocrinol 2002; 146:743-9
19. Giordano TP, Henderson L, Landgren O, et al. Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. JAMA 2007; 297:2010-7
20. Antonelli A, Ferri C, Galeazzi M, et al. HCV infection: pathogenesis, clinical manifestations and therapy. Clin Exp Rheumatol 2008; 26(1 Suppl 48):39-47
21. Zarebska-Michaluk DA, Lebensztejn DM, Kryczka WM, et al. Extrahepatic manifestations associated with chronic hepatitis C infections in Poland. Adv Med Sci 2010; 55:67-73
22. Goldman M, Lambert P, Tasiaux N, et al. Thyroid-stimulating immunoglobulins in mixed (type II) cryoglobulinemia associated with thyrotoxicosis. Arthritis Rheum 1987; 30:1318-9
23. Castellano Higuera A, Gonzáles Reimers E, Alarcó Hernández B, et al. Hypothyroidism, hemolytic anemia and cryoglobulinemia in a patient with hepatitis C virus infection: efficacy of treatment with alpha-interferon. An Med Interna 2003; 20:391-2
24. Antonelli A, Campatelli A, Di Vito A, et al. Comparison between ethanol sclerotherapy and emptying with injection of saline in treatment of thyroid cysts. Clin Investig 1994; 72:971-4
25. Antonelli A, Ferri C, Fallahi P, et al. Thyroid involvement in patients with overt HCV-related mixed cryoglobulinaemia. QJM 2004; 97:499-506
26. Antonelli A, Ferri C, Fallahi P. Thyroid cancer in patients with hepatitis C infection. JAMA 1999; 281:1588
27. Montella M, Crispo A, Pezzullo L, et al. Is hepatitis C virus infection associated with thyroid cancer? A case-control study. Int J Cancer 2000; 87:611-2
28. Montella M, Crispo A, de Bellis G, et al. HCV and cancer: a case-control study in a high-endemic area. Liver 2001; 21:335-41
29. Antonelli A, Ferri C, Fallahi P, et al. Thyroid cancer in HCVrelated mixed cryoglobulinemia patients. Clin Exp Rheumatol 2002; 20:693-6
30. Fiore E, Rago T, Latrofa F, et al. Hashimoto's thyroiditis is associated with papillary thyroid carcinoma: role of TSH and of treatment with L-thyroxine. Endocr Relat Cancer 2011; 18:429-37
31. Antonelli A, Ferri C, Fallahi P, et al. Thyroid cancer in HCV-related chronic hepatitis patients: a case-control study. Thyroid 2007; 17:447-51
32. Ferri C, Antonelli A, Mascia MT, et al. HCV-related autoimmune and neoplastic disorders: the HCV syndrome. Dig Liver Dis 2007; 39(Suppl 1):13-21
33. Neri S, Antonelli A, Falaschi F, et al. Findings from high resolution computed tomography of the lung and pleura of symptom free workers exposed to amosite who had normal chest radiographs and pulmonary function tests. Occup Environ Med 1994; 51:239-43
34. Antonelli A, Bocci G, La Motta C, et al. Novel pyrazolopyrimidine derivatives as tyrosine kinase inhibitors with antitumoral activity in vitro and in vivo in papillary dedifferentiated thyroid cancer. J Clin Endocrinol Metab 2011; 96:E288-96
35. Tomer Y, Blackard JT, Akeno N. Interferon alpha treatment and thyroid dysfunction. Endocrinol Metab Clin North Am 2007; 36:1051-6636
36. Vezali E, Elefsiniotis I, Mihas C, et al. Thyroid dysfunction in patients with chronic hepatitis C: virus- or therapy-related? J Gastroenterol Hepatol 2009; 24:1024-9
37. Papo T, Oksenhendler E, Izembart M, et al. Antithyroid hormone antibodies induced by interferon-alpha. J Clin Endocrinol Metab 1992; 75:1484-6
38. Mihm S, Schweyer S, Ramadori G. Expression of the chemokine IP-10 correlates with the accumulation of hepatic IFN-gamma and IL-18 mRNA in chronic hepatitis C but not in hepatitis B. J Med Virol 2003; 70:562-70
39. Antonelli A, Ferri C, Ferrari SM, et al. Immunopathogenesis of HCV-related endocrine manifestations in chronic hepatitis and mixed cryoglobulinemia. Autoimmun Rev 2008; 8:18-23
40. Antonelli A, Ferri C, Ferrari, et al. Endocrine manifestations of hepatitis C virus infection. Nat Clin Pract Endocrinol Metab 2009; 5:26-34
41. Apolinario A, Majano PL, Lorente R, et al. Gene expression profile of T-cell-specific chemokines in human hepatocytederived cells: evidence for a synergistic inducer effect of cytokines and hepatitis C virus proteins. J Viral Hepat 2005; 12:27-37
42. Antonelli A, Rotondi M, Fallahi P, et al. Increase of interferongamma-inducible CXC chemokine CXCL10 serum levels in patients with active Graves' disease, and modulation by methimazole therapy. Clin Endocrinol (Oxf) 2006; 64:189-95
43. Antonelli A, Rotondi M, Fallahi P, et al. Iodine-131 Given for Therapeutic Purposes Modulates Differently Interferon-{gamma}-Inducible {alpha}-Chemokine CXCL10 Serum Levels in Patients with Active Graves' Disease or Toxic Nodular Goiter. J Clin Endocrinol Metab 2007; 92:1485-90
44. Antonelli A, Fallahi P, Rotondi M, et al. Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomy. Br J Surg 2006; 93:1226-31
45. Antonelli A, Rotondi M, Fallahi P, et al. Increase of CXC chemokine CXCL10 and CC chemokine CCL2 serum levels in normal ageing. Cytokine 2006; 34:32-8
46. Antonelli A, Ferri C, Fallahi P, et al. High Values of CXCL10 Serum Levels in Mixed Cryoglobulinemia Associated With Hepatitis C Infection. Am J Gastroenterol 2008; 103:2488-94
47. Antonelli A, Ferrari SM, Fallahi P, et al. Monokine induced by interferon gamma (IFNgamma) (CXCL9) and IFNgamma inducible T-cell alpha-chemoattractant (CXCL11) involvement in Graves' disease and ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists. J Clin Endocrinol Metab 2009; 94:1803-9
48. Antonelli A, Fallahi P, Nesti C, et al. Anti-CD38 autoimmunity in patients with chronic autoimmune thyroiditis or Graves' disease. Clin Exp Immunol 2001; 126:426-31
49. Gowans EJ. Distribution of markers of hepatitis C virus infection throughout the body. Semin Liver Dis 2000; 20:85-102
50. Bartolomé J, Rodríguez-Iñigo E, Quadros P, et al. Detection of hepatitis C virus in thyroid tissue from patients with chronic HCV infection. J Med Virol 2008; 80:1588-94
51. Antonelli A, Fazzi P, Fallahi P, et al. Prevalence of hypothyroidism and Graves disease in sarcoidosis. Chest 2006; 130:526-32
52. Antonelli A, Ferri C, Fallahi P, et al. Alpha-chemokine CXCL10 and beta-chemokine CCL2 serum levels in patientswith hepatitis C-associated cryoglobulinemia in the presence or absence of autoimmune thyroiditis. Metabolism 2008; 57:1270-7
53. Antonelli A, Ferri C, Ferrari SM, et al. The presence of autoimmune thyroiditis in mixed cryoglobulinemia patients is associated with high levels of circulating interleukin-6, but not of tumor necrosis factor-alpha. Clin Exp Rheumatol 2011; 29(1 Suppl 64):17-22
54. Antonelli A, Ferri C, Ferrari SM, et al. Interleukin-1®, C-x-C motif ligand 10, and interferon-gamma serum levels in mixed cryoglobulinemia with or without autoimmune thyroiditis. J Interferon Cytokine Res 2010; 30:835-42
55. Antonelli A, Fallahi P, Ferrari SM, et al. Serum Th1 (CXCL10) and Th2 (CCL2) chemokine levels in children withnewly diagnosed Type 1 diabetes: a longitudinal study. Diabet Med 2008; 25:1349-53
56. Antonelli A, Tuomi T, Nannipieri M, et al. Autoimmunity to CD38 and GAD in Type I and Type II diabetes: CD38 and HLA genotypes and clinical phenotypes. Diabetologia 2002; 45:1298-1306
57. Antonelli A, Baj G, Marchetti P, et al. Human anti-CD38 autoantibodies raise intracellular calcium and stimulate insulin release in human pancreatic islets. Diabetes 2001; 50:985-91
58. Antonelli A, Ferri C, Fallahi P, et al. CXCL10 (alpha) and CCL2 (beta) chemokines in systemic sclerosis--a longitudinal study. Rheumatology (Oxford) 2008;47:45-9